Cardiovascular Diseases: Clinical Trials

64,935 trials for Cardiovascular Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33458 completed, 11353 unknown, 7896 recruiting, 3991 terminated. 24704 Not applicable, 7039 Phase 2, 5242 Phase 3, 4922 Phase 4, 4046 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable24704Completed 12419, Unknown 4192, Recruiting 3297, Not yet recruiting 1491, Terminated 1296, Active not recruiting 985, Withdrawn 708, Enrolling by invitation 224, Suspended 92
Phase 27039Completed 3798, Unknown 879, Terminated 849, Recruiting 635, Withdrawn 331, Active not recruiting 277, Not yet recruiting 215, Suspended 33, Enrolling by invitation 22
Phase 35242Completed 3058, Unknown 686, Terminated 526, Recruiting 456, Not yet recruiting 184, Active not recruiting 164, Withdrawn 135, Enrolling by invitation 19, Suspended 14
Phase 44922Completed 2688, Unknown 995, Terminated 417, Recruiting 363, Withdrawn 172, Not yet recruiting 171, Active not recruiting 79, Enrolling by invitation 25, Suspended 12
Phase 14046Completed 2305, Unknown 468, Terminated 439, Recruiting 356, Withdrawn 176, Active not recruiting 141, Not yet recruiting 132, Suspended 24, Enrolling by invitation 5
Early Phase 1528Completed 200, Unknown 98, Recruiting 87, Terminated 45, Not yet recruiting 44, Withdrawn 30, Active not recruiting 12, Enrolling by invitation 8, Suspended 4

Follow Cardiovascular Diseases: new trials by email Literature Review of Cardiovascular Diseases trials Research Report on Cardiovascular Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance
Vigabatrin Pill, Placebo oral tablet - Hyperinsulinism, Insulin Resistance
Phase 2WithdrawnUniversity of Arizona2030-04-152025-07-30
Effect of Propionic Acid Supplementation on Endothelial Function
Sodium Propionate, Placebo - Cardiovascular Diseases, Endothelial Dysfunction
Not applicableNot yet recruitingMedical College of Wisconsin202029-07-012026-10-30
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease
FGF-1, Placebo - Peripheral Arterial Disease, Stenosis
Phase 1 / Phase 2Not yet recruitingVenturis Therapeutics, Inc.242028-10-152026-08-19
Hemodynamic Evaluation of Left Atrial Pressure in Relationship to Pulmonary Capillary Wedge Pressure in Cardio Thoracic Patients
Cardiogenic Shock, Pulmonary Edema Cardiac Cause
Not yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1362028-09-012026-11-04
Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure
Early Discharge with Lasix® ONYU (furosemide injection, for subcutaneous use) using SQIN-Infusor - Heart Failure, Acute Decompensated Heart Failure
Phase 3Not yet recruitingUniversity of Texas Southwestern Medical Center2502028-08-012026-11-05
The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage
Vectris trial leads and stimulation, Sham - Vasospasm, Cerebral, Aneurysmal Subarachnoid Hemorrhage
Not applicableSuspendedUniversity of Alabama at Birmingham252028-07-312026-09-24
Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia
Ferrous sulfate 325mg - Right Ventricular Dysfunction, Hypoxia
Early Phase 1Not yet recruitingUniversity of Colorado, Denver52028-03-012026-04-29
Effect of Ginger on Heavy Menstrual Bleeding in Women With Coagulation Disorders
Ginger, Placebo - Women With Coagulation Disorders
Early Phase 1Not yet recruitingUniversity of Valladolid742028-02-012026-05-19
MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma
Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway - Multiple Myeloma, Heart Disease Risk Factors
Not applicableNot yet recruitingUniversity of Vermont Medical Center332028-02-012026-08-25
Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction
Heart Failure, Preserved Ejection Fraction
Not yet recruitingBoehringer Ingelheim30002028-01-312026-09-16
Standalone Thoracoscopic Left Atrial Appendage Closure Versus Medical Therapy in Atrial Fibrillation
Video-assisted thoracoscopic closure of the left atrial appendage using a closure device and discontinuation of treatment if the patient is treated with OAC - ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Oral Anticoagulation
Not applicableNot yet recruitingRegion Skane9362028-01-012026-07-15
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Ulinastatin and Thymalfasin, Ulinastatin - Aortic Aneurysm and Dissection
Not applicableNot yet recruitingNanjing Medical University3002027-12-312026-02-02
Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest
Out of Hospital Cardiac Arrest, Computed Tomography
Not yet recruitingNational Taiwan University Hospital50002027-12-312025-11-19
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral Anticoagulation
Abelacimab - Atrial Fibrillation (AF)
Phase 3Not yet recruitingNovartis Pharmaceuticals25002027-12-302026-07-31
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
Acute stroke care Intervention arm - Acute Stroke
Not applicableNot yet recruitingThe George Institute3002027-12-302026-06-11
Registry on Luma Vision's VERAFEYE System (ENLIgHT)
VERAFEYE System - Atrial Fibrillation, Left Atrial Appendage Closure
Not yet recruitingLUMA Vision Ltd.502027-12-152026-11-03
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease
Early Phase 1Not yet recruitingMilton S. Hershey Medical Center302027-12-012026-03-17
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Clinical Decision Aid, Standard Care - Heart Failure, Coronary Artery Disease
Not yet recruitingMedical College of Wisconsin602027-12-012026-11-03
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
YKST02 - Relapsed or Refractory Multiple Myeloma (RRMM)
Phase 2Not yet recruitingExcyte Biopharma Ltd642027-12-012026-11-06
Needle Free Assessment of Myocardial Oxygenation in Healthy Subjects
RespirAct - Coronary Artery Disease
Not applicableNot yet recruitingIndiana University802027-11-012026-10-26

Showing 20 of 64935. Sign in to see all of them.

Narrower conditions

Stroke (7857)  ·  Hypertension (5946)  ·  Heart Failure (5603)  ·  Coronary Artery Disease (4749)  ·  Atrial Fibrillation (3843)  ·  Multiple Myeloma (3675)  ·  Ischemic Stroke (2577)  ·  Heart Diseases (2135)  ·  Myocardial Infarction (1967)  ·  Diabetes Mellitus (1949)  ·  Coronary Disease (1501)  ·  Atherosclerosis (1489)  ·  Acute Coronary Syndrome (1465)  ·  Peripheral Arterial Disease (1362)

Broader conditions

Vascular Diseases (45550)  ·  Heart Diseases (26115)  ·  Pathological Conditions, Signs and Symptoms (22120)  ·  Pathologic Processes (16745)  ·  Nervous System Diseases (14988)  ·  Central Nervous System Diseases (13409)  ·  Brain Diseases (13281)  ·  Cerebrovascular Disorders (12471)  ·  Myocardial Ischemia (9352)  ·  Arterial Occlusive Diseases (8080)  ·  Arteriosclerosis (7592)  ·  Signs and Symptoms (6497)  ·  Nutritional and Metabolic Diseases (5903)  ·  Immune System Diseases (5689)

Interventions

Dexamethasone (915)  ·  Aspirin (607)  ·  Exercise (580)  ·  Clopidogrel (550)  ·  Standard of Care (507)  ·  Bortezomib (486)  ·  Lenalidomide (464)  ·  Cyclophosphamide (427)  ·  Blood Specimen Collection (396)  ·  Sodium Chloride (376)  ·  Rivaroxaban (375)  ·  Amlodipine (365)  ·  Atorvastatin (343)  ·  Saline Solution (319)  ·  Ticagrelor (304)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (684)  ·  Assistance Publique - Hôpitaux de Paris (461)  ·  Assiut University (458)  ·  Mayo Clinic (457)  ·  Abbott Medical Devices (417)  ·  National Taiwan University Hospital (302)  ·  Boston Scientific Corporation (293)  ·  Bayer (287)  ·  Yonsei University (270)  ·  Novartis Pharmaceuticals (269)  ·  AstraZeneca (264)  ·  Boehringer Ingelheim (264)  ·  Brigham and Women's Hospital (257)  ·  University of Pennsylvania (255)  ·  Massachusetts General Hospital (254)

Countries

United States (19109)  ·  China (5974)  ·  France (5030)  ·  Germany (4483)  ·  Canada (3980)  ·  United Kingdom (3883)  ·  Italy (3780)  ·  Spain (2948)  ·  Netherlands (2451)  ·  South Korea (2449)  ·  Belgium (1936)  ·  Denmark (1913)  ·  Turkey (Türkiye) (1810)  ·  Switzerland (1718)  ·  Poland (1669)

Top investigators

Vivek Reddy, MD (38)

Results publications

PMID 33175411, PMID 34813082, PMID 42573020, PMID 35224730, PMID 37870112, PMID 36326435, PMID 36398903, PMID 31867054, PMID 32905623, PMID 33769555, PMID 35244208, PMID 36645250, PMID 38682786, PMID 41114449, PMID 32499241, PMID 34184251, PMID 34196963, PMID 36700520, PMID 32860505, PMID 33107592, PMID 33337539, PMID 33779986, PMID 34932836, PMID 35857365, PMID 39968829, PMID 18190818, PMID 33502773, PMID 38018702, PMID 40875095, PMID 42035974, PMID 19717846, PMID 20961243, PMID 33089502, PMID 34022170, PMID 34487721, PMID 37059239, PMID 37330702, PMID 37565307, PMID 38770818, PMID 39963789, PMID 16731270, PMID 21899409, PMID 31081589, PMID 31535829, PMID 33357481, PMID 34447992, PMID 34515113, PMID 38189593, PMID 38989575, PMID 39526682

NIH funding

2023 (228), 2018 (153), 2019 (139), 2025 (137), 2016 (129), 2017 (118), 2009 (103), 2014 (96), 2015 (94), 2008 (69), P30CA015083 (52), 2005 (44), U10CA180820 (43), P30CA015704 (34), 2004 (25)